• Issue

    Clinical Genetics: Volume 103, Issue 3

    259-379
    March 2023

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 259
  • First Published: 01 February 2023

ORIGINAL ARTICLES

Open Access

FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination

  • Pages: 277-287
  • First Published: 09 November 2022
FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination

Immunofluorescence analysis in a FGF9-D195N mouse model: XY Fgf9D195N/− mice show partial gonadal sex reversal, expressing the meiotic germ cell marker γH2AX (b) and the ovarian somatic cell marker FOXL2 (d). XY Fgf9+/− mice were used as controls (a, c). AMH is a marker of testicular Sertoli cells. Scale bars 100 μm.

Full Access

Bridging clinical care and research in Ontario, Canada: Maximizing diagnoses from reanalysis of clinical exome sequencing data

  • Pages: 288-300
  • First Published: 10 November 2022
Bridging clinical care and research in Ontario, Canada: Maximizing diagnoses from reanalysis of clinical exome sequencing data

Reanalysis of 287 nondiagnostic clinical exomes from Ontario, Canada revealed few missed diagnoses by the clinical laboratories and the incremental gain from reanalysis of clinically-relevant genes is modest. The highest yield came from translational research methods to validate novel disease-gene associations.

Full Access

Identification of nonfunctional SPATA20 causing acephalic spermatozoa syndrome in humans

  • Pages: 310-319
  • First Published: 21 November 2022
Identification of nonfunctional SPATA20 causing acephalic spermatozoa syndrome in humans

Biallelic variants in SPATA20 resulted in acephalic spermatozoa syndrome in humans, characterized by disrupted assembling of head-tail coupling apparatus (HTCA) and aberrant sperm tail.

Full Access

A comprehensive functional analysis on the pathogenesis of novel TSPAN12 and NDP variants in familial exudative vitreoretinopathy

  • Pages: 320-329
  • First Published: 01 December 2022
A comprehensive functional analysis on the pathogenesis of novel TSPAN12 and NDP variants in familial exudative vitreoretinopathy

Targeted sequencing and Sanger sequencing identified NDP and TSPAN12 variants from FEVR patients. The four missense variants in TSPAN12 cause defective membrane trafficking ability, leading to decreased Norrin/β-catenin signaling. The Cys119Tyr and His42Asn variants in NDP cause compromised Norrin/β-catenin signaling by disrupting interactions with FZD4 and LRP5, respectively, which can be enhanced by over-expression of TSPAN12.

SHORT REPORTS

Full Access

Management of copy number variants associated with incomplete penetrance and variable expressivity—Results of a French survey

  • Pages: 335-340
  • First Published: 23 October 2022
Management of copy number variants associated with incomplete penetrance and variable expressivity—Results of a French survey

French healthcare professionals have to face with challenging report and genetic counseling regarding PIEV CNVs. Our study consists in purposing them a survey about their opinions and practices of which results highlight that multidisciplinary concertation has to be the main basis for French recommendations.

Full Access

A novel variant in AFF3 underlying isolated syndactyly

  • Pages: 341-345
  • First Published: 23 October 2022
A novel variant in AFF3 underlying isolated syndactyly

We report a novel heterozygous missense variant in AFF3 (c.2915G > C: p.Arg972Pro) associated with isolated syndactyly. Our zebrafish assay suggested that the variant is loss-of-function. Our results establish the first association of AFF3 with isolated syndactyly and expand the clinical spectrum associated with variants in AFF3.

Open Access

Putative founder effect of Arg338* AP4M1 (SPG50) variant causing severe intellectual disability, epilepsy and spastic paraplegia: Report of three families

  • Pages: 346-351
  • First Published: 13 November 2022
Putative founder effect of Arg338* AP4M1 (SPG50) variant causing severe intellectual disability, epilepsy and spastic paraplegia: Report of three families

In this study we report three new unrelated patients from Middle-East consanguineous families carrying the previously described NM_004722.4(AP4M1):c.1012C〉T homozygous nonsense variant. We describe their phenotype, and provide evidence that the subjects carrying this variant originate from a common ancestor.

Full Access

Genetic screening in patients with ovarian dysfunction

  • Pages: 352-357
  • First Published: 13 November 2022
Genetic screening in patients with ovarian dysfunction

We identified eight potential variants in five genes (MSH4, HFM1, SYCE1, FSHR and C14orf39) from six independent families in infertile females characterized by ovarian dysfunction with exome sequencing. The missense variants in FSHR were conserved across species. And the splice-site variants in MSH4 and SYCE1 affected canonical splicing isoforms, leading to missing protein domains or premature termination.

Open Access

Aminoacylation-defective bi-allelic mutations in human EPRS1 associated with psychomotor developmental delay, epilepsy, and deafness

  • Pages: 358-363
  • First Published: 21 November 2022
Aminoacylation-defective bi-allelic mutations in human EPRS1 associated with psychomotor developmental delay, epilepsy, and deafness

We report compound heterozygous variants in a bifunctional aminoacyl-tRNA synthetase, EPRS1, in a 4-year-old female patient presenting with psychomotor developmental delay, seizures and deafness. Functional studies of these two missense mutations support major defects in enzymatic function in vitro and contributed to confirmation of the diagnosis.

Full Access

Novel de novo ZNF148 truncating variant causing autism spectrum disorder, attention deficit hyperactivity disorder, and intellectual disability

  • Pages: 364-368
  • First Published: 28 November 2022
Novel de novo ZNF148 truncating variant causing autism spectrum disorder, attention deficit hyperactivity disorder, and intellectual disability

We first identify a novel ZNF148 heterozygous truncating variant c.1818dupC (p.Lys607Glnfs*11) in a patient with distinct phenotypes of ASD and ADHD. This variation produces a ZNF148 truncated protein with a deletion of the C-terminal activation domain and may destabilize the protein by affecting the transcriptional activation function.

RESEARCH LETTERS

Full Access

New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortage

  • Pages: 371-376
  • First Published: 13 November 2022
New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortage

The update of the review on the effects of switching from agalsidase beta to alfa showed, in comparison to the previous review, an increased number of clinical events, a significant loss of renal function, and an increase in lyso Gb-3 levels, underscoring the importance of dose in the treatment of FD.